These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 19892751

  • 1. Restoration of reversed whole PTH/intact PTH ratio and reduction in parathyroid gland vascularity during cinacalcet therapy for severe hyperparathyroidism in a uraemic patient.
    Komaba H, Shin J, Fukagawa M.
    Nephrol Dial Transplant; 2010 Feb; 25(2):638-41. PubMed ID: 19892751
    [Abstract] [Full Text] [Related]

  • 2. Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?
    Kakuta T, Tanaka R, Kanai G, Sawaya A, Hirukawa T, Sato A, Saito A.
    Ther Apher Dial; 2009 Oct; 13 Suppl 1():S20-7. PubMed ID: 19765255
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical remission as measured by a decrease in intact parathyroid hormone levels after administration of cinacalcet in patients with severe hyperparathyroidism.
    Battistella M, Hamandi B, Pui C, Oreopoulos D, Richardson R, Jassal SV.
    Nephrol Dial Transplant; 2008 Feb; 23(2):773-4. PubMed ID: 17977873
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Calcimimetics--fooling the calcium receptor.
    Ritz E.
    Pediatr Nephrol; 2005 Jan; 20(1):15-8. PubMed ID: 15517414
    [Abstract] [Full Text] [Related]

  • 11. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.
    Arakawa T, D'Amour P, Rousseau L, Brossard JH, Sakai M, Kasumoto H, Igaki N, Goto T, Cantor T, Fukagawa M.
    Clin J Am Soc Nephrol; 2006 May; 1(3):525-31. PubMed ID: 17699255
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.
    Serra AL, Wuhrmann C, Wüthrich RP.
    Am J Kidney Dis; 2008 Dec; 52(6):1151-7. PubMed ID: 18950915
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
    Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P, Albizem MB, Guo MD, Zani VJ, Goodman WG, Sprague SM.
    Nephrol Dial Transplant; 2005 Oct; 20(10):2186-93. PubMed ID: 16030053
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl.
    Martin KJ, Jüppner H, Sherrard DJ, Goodman WG, Kaplan MR, Nassar G, Campbell P, Curzi M, Charytan C, McCary LC, Guo MD, Turner SA, Bushinsky DA.
    Kidney Int; 2005 Sep; 68(3):1236-43. PubMed ID: 16105056
    [Abstract] [Full Text] [Related]

  • 19. Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients.
    Fukagawa M, Yumita S, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S, KRN1493 study group.
    Nephrol Dial Transplant; 2008 Jan; 23(1):328-35. PubMed ID: 17717030
    [Abstract] [Full Text] [Related]

  • 20. Cinacalcet in hyperfunctioning parathyroid diseases.
    Imanishi Y, Inaba M, Kawata T, Nishizawa Y.
    Ther Apher Dial; 2009 Oct; 13 Suppl 1():S7-S11. PubMed ID: 19765257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.